AQEMIA is a next-gen pharmatech company generating one of the world's fastest-growing drug discovery pipeline. Our mission is to design fast innovative drug candidates for dozens of critical diseases, such as immuno-oncology.



Our unique approach leverages quantum-inspired physics algorithms to power generative AI in designing novel drug candidates—without relying on experimental data. We already delivered several drug discovery successes within our internal pipeline and through collaborations with pharmaceutical companies.

Our most advanced programs are currently in vivo optimization.



Aqemia is proud to be part of the French Tech 120 program, which supports the most promising scale-ups in France with high potential for global impact.





AQEMIA is based in Paris and London.



We are growing and hiring! Check our career website: https://jobs.lever.co/aqemia.com



Discover the roles and behind-the-scenes at AQEMIA on our Welcome To The Jungle page: https://www.welcometothejungle.com/fr/companies/aqemia